×
About 6,988 results

ALLMedicine™ Fetal Growth Restriction Center

Research & Reviews  3,447 results

The RNA landscape of the human placenta in health and disease.
https://doi.org/10.1038/s41467-021-22695-y 10.1126/science.aaz1776 10.1038/s41556-019-0311-8 10.1038/s41588-018-0298-2 10.1016/j.placenta.2009.01.012 10.1073/pnas.0508035103 10.1186/1471-2164-13-115 10.1186/s13293-018-0165-y 10.1186/s12864-016-3384-9 10.1038/srep13336 10.1016/j.placenta.2016.10.011 10.1016/S0140-6736(15)00131-2 10.1186/1471-2393-8-51 10.1038/nrg2438 10.1186/gb-2011-12-2-r16 10.1016/j.placenta.2013.11.002 10.1093/nar/gkz415 10.1186/s12859-018-2287-y 10.1038/nbt.3122 10.1038/nmeth.4078 10.1038/nbt.1621 10.1186/s13059-018-1590-2 10.1007/s00109-017-1582-9 10.1261/rna.043687.113 10.1016/j.cell.2018.12.021 10.1038/nature11993 10.1038/nature11928 10.1186/gb-2003-5-1-r1 10.1093/nar/gkt1181 10.1016/j.molcel.2015.03.027 10.1038/nature13302 10.1016/j.molcel.2017.02.017 10.15252/msb.20188503 10.1186/1471-2105-9-559 10.3389/fbioe.2020.00177 10.1038/s41591-020-0804-9 10.1016/j.cub.2019.04.040 10.1002/path.4068 10.1073/pnas.0903775106 10.1038/nm970 10.1136/bmj.l2381 10.1016/j.ejcb.2017.09.004 10.1146/annurev-genet-120417-031441 10.1038/s42003-017-0001-7 10.1016/j.tibs.2016.05.004 10.1073/pnas.1821120116 10.1038/nmeth.3478 10.15252/msb.20199275 10.1038/s42003-018-0239-8 10.1016/j.molcel.2011.06.022 10.1093/nar/gkx1075 10.1016/j.canlet.2019.05.007 10.1093/nar/gku620 10.1261/rna.066126.118 10.1016/j.bbrc.2019.08.015 10.1038/s41576-019-0158-7 10.15252/embj.2018100836 10.1038/s41467-020-18355-2 10.1159/000359969 10.1016/j.ajog.2010.08.009 10.1016/j.placenta.2013.12.008 10.1093/ndt/gfw472 10.1155/2014/364209 10.3389/fgene.2018.00706 10.1111/imr.12323 10.1046/j.1469-0705.1995.06030168.x 10.1186/s13059-014-0550-8 10.1371/journal.pone.0023595 10.1210/jc.2010-2310 10.14806/ej.17.1.200 10.1186/gb-2013-14-4-r36 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1093/nar/gkr688 10.1186/gb-2009-10-3-r25 10.1093/bib/bbs038 10.1093/bioinformatics/btq033 10.1161/HYPERTENSIONAHA.116.08620 10.1016/j.placenta.2019.04.005 10.1093/nar/gkx1098 10.1093/nar/gkz369 10.1093/nar/gkp335 10.1093/nar/gks1262 10.1093/nar/gky092 10.1021/acs.analchem.8b03224 10.1007/s13361-016-1460-7 10.1038/nmeth.4338 10.1093/bioinformatics/btt656 10.1038/nmeth.4197 10.1186/gb-2010-11-3-r25 10.1093/bioinformatics/btp616 10.1093/bioinformatics/bti042 10.1136/adc.73.1.17 10.1101/gr.772403
Nature Communications; Gong S, Gaccioli F et. al.

May 12th, 2021 - The placenta is the interface between mother and fetus and inadequate function contributes to short and long-term ill-health. The placenta is absent from most large-scale RNA-Seq datasets. We therefore analyze long and small RNAs (~101 and 20 mill...

Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction.
https://doi.org/10.1016/j.ogc.2021.02.001
Obstetrics and Gynecology Clinics of North America; Dumolt JH, Powell TL et. al.

May 11th, 2021 - Placental regulation of fetal growth involves the integration of multiple signaling pathways that modulate an array of placental functions, including nutrient transport. As a result, the flux of oxygen and nutrients to the fetus is altered, leadin...

Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for G...
https://doi.org/10.1016/j.ogc.2021.02.002
Obstetrics and Gynecology Clinics of North America; Damhuis SE, Ganzevoort W et. al.

May 11th, 2021 - Abnormal fetal growth (growth restriction and overgrowth) is associated with perinatal morbidity, mortality, and lifelong risks to health. To describe abnormal growth, "small for gestational age" and "large for gestational age" are commonly used t...

Fetal Growth and Stillbirth.
https://doi.org/10.1016/j.ogc.2021.03.001
Obstetrics and Gynecology Clinics of North America; Page JM, Blue NR et. al.

May 11th, 2021 - Fetal growth restriction (FGR) is a common clinical manifestation of placental insufficiency. As such, FGR is a risk factor for stillbirth. This association has been demonstrated in numerous studies but is prone to overestimation because of the po...

Short- and Long-Term Implications of Small for Gestational Age.
https://doi.org/10.1016/j.ogc.2021.02.004
Obstetrics and Gynecology Clinics of North America; Fung C, Zinkhan E

May 11th, 2021 - Fetal growth restriction (FGR) describes a fetus' inability to attain adequate weight gain based on genetic potential and gestational age and is the second most common cause of perinatal morbidity and mortality after prematurity. Infants who have ...

see more →

Guidelines  21 results

Fetal Growth Restriction: ACOG Practice Bulletin, Number 227.
https://doi.org/10.1097/AOG.0000000000004251 10.1038/jp.2012.130
Obstetrics and Gynecology;

Jan 22nd, 2021 - Fetal growth restriction, also known as intrauterine growth restriction, is a common complication of pregnancy that has been associated with a variety of adverse perinatal outcomes. There is a lack of consensus regarding terminology, etiology, and...

Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fet...
https://doi.org/10.1016/j.ajog.2020.05.010
American Journal of Obstetrics and Gynecology; , Martins JG et. al.

May 14th, 2020 - Fetal growth restriction can result from a variety of maternal, fetal, and placental conditions. It occurs in up to 10% of pregnancies and is a leading cause of infant morbidity and mortality. This complex obstetrical problem has disparate publish...

Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restrictio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081556
American Journal of Obstetrics and Gynecology; , Lauder J et. al.

May 3rd, 2020 - Despite current recommendations against its use, activity restriction remains a common intervention used to prevent preterm birth in multiple clinical settings. Hypertensive disorders of pregnancy, preterm premature rupture of membranes, multiple ...

ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.
https://doi.org/10.1002/uog.20272
Ultrasound in Obstetrics & Gynecology : the Official Jour... Salomon LJ, Alfirevic Z et. al.

Jun 6th, 2019 - INTRODUCTION These Guidelines aim to describe appropriate assessment of fetal biometry and diagnosis of fetal growth disorders. These disorders consist mainly of fetal growth restriction (FGR), also referred to as intrauterine growth restriction (...

ACR Appropriateness Criteria® Growth Disturbances-Risk of Fetal Growth Restriction.
https://doi.org/10.1016/j.jacr.2019.02.009
Journal of the American College of Radiology : JACR; , Shipp TD et. al.

May 5th, 2019 - Fetal growth restriction, or an estimated fetal weight of less than the 10th percentile, is associated with adverse perinatal outcome. Optimizing management for obtaining the most favorable outcome for mother and fetus is largely based on detailed...

see more →

Clinicaltrials.gov  3,469 results

The RNA landscape of the human placenta in health and disease.
https://doi.org/10.1038/s41467-021-22695-y 10.1126/science.aaz1776 10.1038/s41556-019-0311-8 10.1038/s41588-018-0298-2 10.1016/j.placenta.2009.01.012 10.1073/pnas.0508035103 10.1186/1471-2164-13-115 10.1186/s13293-018-0165-y 10.1186/s12864-016-3384-9 10.1038/srep13336 10.1016/j.placenta.2016.10.011 10.1016/S0140-6736(15)00131-2 10.1186/1471-2393-8-51 10.1038/nrg2438 10.1186/gb-2011-12-2-r16 10.1016/j.placenta.2013.11.002 10.1093/nar/gkz415 10.1186/s12859-018-2287-y 10.1038/nbt.3122 10.1038/nmeth.4078 10.1038/nbt.1621 10.1186/s13059-018-1590-2 10.1007/s00109-017-1582-9 10.1261/rna.043687.113 10.1016/j.cell.2018.12.021 10.1038/nature11993 10.1038/nature11928 10.1186/gb-2003-5-1-r1 10.1093/nar/gkt1181 10.1016/j.molcel.2015.03.027 10.1038/nature13302 10.1016/j.molcel.2017.02.017 10.15252/msb.20188503 10.1186/1471-2105-9-559 10.3389/fbioe.2020.00177 10.1038/s41591-020-0804-9 10.1016/j.cub.2019.04.040 10.1002/path.4068 10.1073/pnas.0903775106 10.1038/nm970 10.1136/bmj.l2381 10.1016/j.ejcb.2017.09.004 10.1146/annurev-genet-120417-031441 10.1038/s42003-017-0001-7 10.1016/j.tibs.2016.05.004 10.1073/pnas.1821120116 10.1038/nmeth.3478 10.15252/msb.20199275 10.1038/s42003-018-0239-8 10.1016/j.molcel.2011.06.022 10.1093/nar/gkx1075 10.1016/j.canlet.2019.05.007 10.1093/nar/gku620 10.1261/rna.066126.118 10.1016/j.bbrc.2019.08.015 10.1038/s41576-019-0158-7 10.15252/embj.2018100836 10.1038/s41467-020-18355-2 10.1159/000359969 10.1016/j.ajog.2010.08.009 10.1016/j.placenta.2013.12.008 10.1093/ndt/gfw472 10.1155/2014/364209 10.3389/fgene.2018.00706 10.1111/imr.12323 10.1046/j.1469-0705.1995.06030168.x 10.1186/s13059-014-0550-8 10.1371/journal.pone.0023595 10.1210/jc.2010-2310 10.14806/ej.17.1.200 10.1186/gb-2013-14-4-r36 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1093/nar/gkr688 10.1186/gb-2009-10-3-r25 10.1093/bib/bbs038 10.1093/bioinformatics/btq033 10.1161/HYPERTENSIONAHA.116.08620 10.1016/j.placenta.2019.04.005 10.1093/nar/gkx1098 10.1093/nar/gkz369 10.1093/nar/gkp335 10.1093/nar/gks1262 10.1093/nar/gky092 10.1021/acs.analchem.8b03224 10.1007/s13361-016-1460-7 10.1038/nmeth.4338 10.1093/bioinformatics/btt656 10.1038/nmeth.4197 10.1186/gb-2010-11-3-r25 10.1093/bioinformatics/btp616 10.1093/bioinformatics/bti042 10.1136/adc.73.1.17 10.1101/gr.772403
Nature Communications; Gong S, Gaccioli F et. al.

May 12th, 2021 - The placenta is the interface between mother and fetus and inadequate function contributes to short and long-term ill-health. The placenta is absent from most large-scale RNA-Seq datasets. We therefore analyze long and small RNAs (~101 and 20 mill...

Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction.
https://doi.org/10.1016/j.ogc.2021.02.001
Obstetrics and Gynecology Clinics of North America; Dumolt JH, Powell TL et. al.

May 11th, 2021 - Placental regulation of fetal growth involves the integration of multiple signaling pathways that modulate an array of placental functions, including nutrient transport. As a result, the flux of oxygen and nutrients to the fetus is altered, leadin...

Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for G...
https://doi.org/10.1016/j.ogc.2021.02.002
Obstetrics and Gynecology Clinics of North America; Damhuis SE, Ganzevoort W et. al.

May 11th, 2021 - Abnormal fetal growth (growth restriction and overgrowth) is associated with perinatal morbidity, mortality, and lifelong risks to health. To describe abnormal growth, "small for gestational age" and "large for gestational age" are commonly used t...

Fetal Growth and Stillbirth.
https://doi.org/10.1016/j.ogc.2021.03.001
Obstetrics and Gynecology Clinics of North America; Page JM, Blue NR et. al.

May 11th, 2021 - Fetal growth restriction (FGR) is a common clinical manifestation of placental insufficiency. As such, FGR is a risk factor for stillbirth. This association has been demonstrated in numerous studies but is prone to overestimation because of the po...

Short- and Long-Term Implications of Small for Gestational Age.
https://doi.org/10.1016/j.ogc.2021.02.004
Obstetrics and Gynecology Clinics of North America; Fung C, Zinkhan E

May 11th, 2021 - Fetal growth restriction (FGR) describes a fetus' inability to attain adequate weight gain based on genetic potential and gestational age and is the second most common cause of perinatal morbidity and mortality after prematurity. Infants who have ...

see more →

News  51 results

Prenatal betamethasone not linked to later adverse neurocognitive problems
https://www.mdedge.com/obgyn/article/195928/obstetrics/prenatal-betamethasone-not-linked-later-adverse-neurocognitive?channel=27970
Tara Haelle

Mar 8th, 2019 - Administering prenatal corticosteroids to women at risk for preterm birth does not appear to contribute to adverse neurocognitive function in children 6-8 years later, regardless of whether they had fetal growth restriction, a new study found. Pho.

Sildenafil associated with persistent pulmonary hypertension in neonates with early IUGR
https://www.mdedge.com/familymedicine/article/194749/obstetrics/sildenafil-associated-persistent-pulmonary-hypertension?channel=39313
MDedge ObGyn; Michele G. Sullivan

Feb 19th, 2019 - LAS VEGAS – Increased rates of persistent neonatal pulmonary hypertension in neonates put the brakes on STRIDER, an international placebo-controlled study looking at sildenafil as a treatment for early-onset intrauterine growth restriction (IUGR).

Abruptio placenta brings increased cardiovascular risk – and soon
https://www.mdedge.com/familymedicine/article/159781/heart-failure/abruptio-placenta-brings-increased-cardiovascular-risk
Cardiology News; Bruce Jancin

Feb 28th, 2018 - ANAHEIM, CALIF. – Women who experience placental abruption are at significantly increased risk for multiple forms of cardiovascular disease beginning within the first few years after their pregnancy complication, according to a study of more than.

Preterm Birth Tied to Sleep Problems Well Into Childhood
https://www.medscape.com/viewarticle/890000

Dec 13th, 2017 - NEW YORK (Reuters Health) - Children born preterm may experience poorer sleep quality and quantity when they reach school age, compared with kids born at term, according to a small study. The findings, the authors write, “suggest that premature bi...

Vitamin D Linked to Fertility Outcomes in ART
https://www.medpagetoday.com/endocrinology/infertility/69343

Nov 16th, 2017 - Action Points Adequate levels of vitamin D were associated with better fertility outcomes in women undergoing assisted reproduction treatment (ART), according to a meta-analysis of 11 recent studies including 2,700 women. Note that vitamin D defic...

see more →